Recruiting Triple Negative Breast Cancer Studies in Boston
About Triple Negative Breast Cancer Clinical Trials in Boston
Triple-negative breast cancer (TNBC) lacks estrogen receptors, progesterone receptors, and excess HER2 protein, limiting targeted treatment options. It accounts for about 10-15% of breast cancers and tends to be more aggressive. Active research focuses on immunotherapy and novel drug combinations.
There are currently 6 triple negative breast cancer clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 876 participants. Research is being sponsored by Day One Biopharmaceuticals, Inc., Massachusetts General Hospital, Dana-Farber Cancer Institute and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Triple Negative Breast Cancer Clinical Trials in Boston — FAQ
Are there triple negative breast cancer clinical trials in Boston?
Yes, there are 6 triple negative breast cancer clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What triple negative breast cancer treatments are being tested?
The 6 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for triple negative breast cancer.
Data updated October 19, 2026 from ClinicalTrials.gov